Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Nielsen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Endocrinology|September 1, 1994
Agents that increase phosphatidic acid inhibit the LH-induced testosterone productionL Lauritzen, L L Nielsen, A M Vinggaard, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancerM Gurnani, P Lipari, J Dell, et al.
Cancer Research|July 15, 1991
Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogeneL L Nielsen, C M Discafani, M Gurnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancerL L Nielsen, P Lipari, J Dell, et al.
Nutrition and Cancer|January 1, 1992
Effect of dietary fiber on the disposition and excretion of a food carcinogen (2-14C-labeled MeIQx) in ratsP Sjödin, M Nyman, L L Nielsen, et al.
Molecular Cancer Therapeutics|December 7, 2002
The role of natural killer cells in adenovirus-mediated p53 gene therapyJ L Carroll, L L Nielsen, S B Pruett, et al.
Methods in Enzymology|June 13, 2001
Orally bioavailable farnesyltransferase inhibitors as anticancer agents in transgenic and xenograft modelsM Liu, W R Bishop, L L Nielsen, et al.
Cancer Gene Therapy|March 1, 1997
Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenograftsL L Nielsen, J Dell, E Maxwell, et al.
In Vivo (Athens, Greece)|May 1, 1994
Development of a nude mouse model of ras-mediated neoplasia using WR21 cells from a transgenic mouse salivary tumorL L Nielsen, M Gurnani, G Porter, et al.
Scandinavian Journal of Immunology|October 16, 1999
A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficientlyC Sylvester-Hvid, L L Nielsen, N J Hansen, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Endocrinology|September 1, 1994
Agents that increase phosphatidic acid inhibit the LH-induced testosterone productionL Lauritzen, L L Nielsen, A M Vinggaard, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancerM Gurnani, P Lipari, J Dell, et al.
Cancer Research|July 15, 1991
Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogeneL L Nielsen, C M Discafani, M Gurnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancerL L Nielsen, P Lipari, J Dell, et al.
Nutrition and Cancer|January 1, 1992
Effect of dietary fiber on the disposition and excretion of a food carcinogen (2-14C-labeled MeIQx) in ratsP Sjödin, M Nyman, L L Nielsen, et al.
Molecular Cancer Therapeutics|December 7, 2002
The role of natural killer cells in adenovirus-mediated p53 gene therapyJ L Carroll, L L Nielsen, S B Pruett, et al.
Methods in Enzymology|June 13, 2001
Orally bioavailable farnesyltransferase inhibitors as anticancer agents in transgenic and xenograft modelsM Liu, W R Bishop, L L Nielsen, et al.
Cancer Gene Therapy|March 1, 1997
Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenograftsL L Nielsen, J Dell, E Maxwell, et al.
In Vivo (Athens, Greece)|May 1, 1994
Development of a nude mouse model of ras-mediated neoplasia using WR21 cells from a transgenic mouse salivary tumorL L Nielsen, M Gurnani, G Porter, et al.
Scandinavian Journal of Immunology|October 16, 1999
A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficientlyC Sylvester-Hvid, L L Nielsen, N J Hansen, et al.
Pageof 4